Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Venezuela devalues its Bolivar; CPG firms adjust outlook

This article was originally published in The Rose Sheet

Executive Summary

U.S. companies with business in Latin America, where growth has continued despite the global recession, are likely to see reduced earnings in Venezuela as the value of the bolivar drops from approximately 2.15 to 2.6 per dollar for essential goods and 4.3 for non-essentials, in accordance with President Hugo Chavez's devaluation of the country's currency. Colgate-Palmolive expects its products to fall into the non-essential category, according to Jan. 11 release. The devaluation won't affect the firm's 2009 results or competitive position, Colgate says. In the first quarter of fiscal 2010, the firm anticipates recording a one-time gain of $60 mil. ($0.12 per share) and ongoing quarterly charges of $0.04 to $0.06 per share related to the devaluation. The Venezuelan market reportedly represents about 9 percent of Colgate's profits. Procter & Gamble, Avon Products and Burt's Bees owner Clorox Co. are also expected to be affected by the devaluation

Latest Headlines
See All
UsernamePublicRestriction

Register

RS016677

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel